A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06083207 · RECRUITING
Trial details
- NCT number
- NCT06083207
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2026-10-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.